Effect of Dapagliflozin and Magnesium Supplementation on Renal Magnesium Handling and Magnesium Homeostasis in Metabolic Syndrome
The prevalence of metabolic syndrome (MetS) is increasing, and patients with MetS are at an increased risk of cardiovascular disease and diabetes. There is a close link between hypomagnesemia and MetS. Administration of sodium-glucose transporter 2 (SGLT2) inhibitors has been reported to increase se...
Guardado en:
Autores principales: | Hwee-Yeong Ng, Wei-Hung Kuo, You-Lin Tain, Foong-Fah Leung, Wen-Chin Lee, Chien-Te Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/79f591184c54478c84ec887f2cb7a2bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oral Magnesium Supplementation for Treating Glucose Metabolism Parameters in People with or at Risk of Diabetes: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials
por: Nicola Veronese, et al.
Publicado: (2021) -
Causal Effect of Serum Magnesium on Osteoporosis and Cardiometabolic Diseases
por: Bin He, et al.
Publicado: (2021) -
Association between Dietary Magnesium Intake and Glycemic Markers in Ghanaian Women of Reproductive Age: A Pilot Cross-Sectional Study
por: Helena J. Bentil, et al.
Publicado: (2021) -
Magnesium parameters and their association with lipid metabolism markers in obese women
por: Santos,Loanne Rocha dos, et al.
Publicado: (2021) -
Magnesium deficiency and increased inflammation: current perspectives
por: Nielsen FH
Publicado: (2018)